Day: February 14, 2024

Kinross reports 2023 fourth-quarter and full-year results

Kinross reports 2023 fourth-quarter and full-year results

Appendix B LP long section demonstrating potential for extension of a high-grade underground resource Figure 1 Curlew Basin Cross Section Figure 2 Alaska Exploration Intercept Highlights Figure 3 SENISA and TMLSA License Map Figure 4 SENISA Main Target Areas Figure 5 Cerros Bravos Location Map Figure 6 Snow Lake, Manitoba, Property Location Map Delivers on 2023 guidance, strong 2024 outlook of 2.1 million Au eq. oz.Tasiast and La Coipa projects completed driving significant free cash flowGreat Bear exceeds expectations and adds more than one million high-grade inferred ounces TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K, NYSE: KGC) (“Kinross” or the “Company”) today announced its results for the fourth-quarter and year ended December 31, 2023. This...

Continue reading

Dundee Precious Metals Continues Record of Strong Free Cash Flow Generation; Announces 2023 Financial Results and Updated Three-Year Outlook

Dundee Precious Metals Continues Record of Strong Free Cash Flow Generation; Announces 2023 Financial Results and Updated Three-Year Outlook

      TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or the “Company”) announced its operating and financial results for the quarter and year ended December 31, 2023. Highlights (Unless otherwise stated, all monetary figures in this news release are expressed in U.S. dollars, and all operational and financial information contained in this news release is related to continuing operations.) Strong metals production: Produced 296,072 ounces of gold and 30.5 million pounds of copper, in line with 2023 guidance. All-in sustaining cost: Reported cost of sales per ounce of gold sold1 of $919 and an all-in sustaining cost per ounce of gold sold2 of $849, in line with 2023 guidance. Significant free cash flow: Generated $261.6 million of cash provided from operating activities and free cash flow2...

Continue reading

Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Posts Adjusted EBITDA Margin of 23.5% and 2% Sequential Organic Growth CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal 2024 financial results and operational highlights. These results pertain to the three months ended December 31, 2023, and are reported in United States dollars (“$”, “dollars” and “US$”) and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, February 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor section of the Company’s website through...

Continue reading

Treasure Global Reports Second Quarter Fiscal Year 2024 Results

Treasure Global Reports Second Quarter Fiscal Year 2024 Results

Increased Registered Users to Over 2.68 Million as of December 31, 2023 Reported Gross Profit of Approximately $0.35 Million for Second Quarter Fiscal 2024, up 48% Year-Over-Year Closed $4.0 Million Public Offering and Signed Agreement to Retire Convertible Debt Notes Hosted First-Ever AI Robot for TikTok Live Commerce in Malaysia Announced Collaboration with AIO Synergy Solutions on Development of Data Center for AI Applications NEW YORK and KUALA LUMPUR, Malaysia, Feb. 14, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“TGL,” “Treasure Global” or the “Company”), an innovative technology solutions provider, today reported its financial results for the second quarter of the 2024 fiscal year ended December 31, 2023, and provided a business update. “TGL continued to be a leading innovator in our markets, hosting first-ever...

Continue reading

Birchcliff Energy Ltd. Announces Unaudited 2023 Full-Year and Fourth Quarter Results and 2023 Reserves Highlights

Birchcliff Energy Ltd. Announces Unaudited 2023 Full-Year and Fourth Quarter Results and 2023 Reserves Highlights

CALGARY, Alberta, Feb. 14, 2024 (GLOBE NEWSWIRE) — Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce its unaudited 2023 full-year and fourth quarter financial and operational results and highlights from its independent reserves evaluation effective December 31, 2023. “In 2023, we delivered annual average production of 75,699 boe/d and adjusted funds flow(1) of $306.8 million and returned $224.8 million to shareholders through common share dividends and share repurchases under our normal course issuer bid,” commented Chris Carlsen, President and Chief Executive Officer of Birchcliff. “We achieved a PDP F&D operating netback recycle ratio(2) of 1.1x in a low commodity price environment, notwithstanding $58.0 million of capital spent on strategic priorities that did not add reserves...

Continue reading

ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

SOUTH SAN FRANCISCO and SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Citi 2024 Virtual Oncology Leadership Summit on Wednesday, February 21, 2024, at 3:00 p.m. ET. A live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following each event. About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114,...

Continue reading

Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results

Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results

Expected to Save $4.0 Million Annualized On Target for Second Half 2024 Adjusted EBITDA Profitability Fourth Quarter 2023 Net Revenue Range Improved to $31.2 Million to $32.0 Million Expected Adjusted EBITDA Loss Range Improved to $(6.3) Million to $(5.5) Million NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced a fixed cost reduction as part of the final steps of its previously announced SKU rationalization program. The Company also released certain preliminary fourth quarter 2023 results. Fixed Cost Reduction PlanThe fixed cost reduction plan is expected to align the Company’s costs to what the Company believes will be the appropriate level as it drives towards adjusted EBITDA profitability in the second half of 2024. The Company expects to reduce its workforce...

Continue reading

3D Systems Announces Date of Fourth Quarter and Full Year 2023 Financial Results

3D Systems Announces Date of Fourth Quarter and Full Year 2023 Financial Results

ROCK HILL, S.C., Feb. 14, 2024 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) announced today it will release its financial results for the fourth quarter and full year 2023 after the U.S. stock markets close on Tuesday, February 27, 2024. The company will hold a conference call and simultaneous webcast to discuss these financial results on Wednesday, February 28, 2024 at 8:30 a.m. Eastern Time. Fourth Quarter and Full Year 2023 Financial Results Conference CallDate: Wednesday, February 28, 2024Time: 8:30 a.m. Eastern TimeListen via webcast: www.3dsystems.com/investorParticipate via telephone: 201-689-8345 The webcast replay will be available approximately two hours after the end of the conference call at www.3dsystems.com/investor. About 3D Systems More than 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing...

Continue reading

Marathon Digital Holdings Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Marathon Digital Holdings Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Earnings Webcast and Conference Call Set for Wednesday, February 28, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, Feb. 14, 2024 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), a leader in supporting and securing the Bitcoin ecosystem, will hold a webcast and conference call on Wednesday, February 28, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial results will be published in a press release prior to the call and available on the investor relations section of the Company’s website. To register to participate in the conference call or to listen to the live audio webcast, please use this link. The webcast will also be broadcast live and available for replay via the investor relations...

Continue reading

Kadant Reports Fourth Quarter and Fiscal Year 2023 Results

Kadant Reports Fourth Quarter and Fiscal Year 2023 Results

Record Revenue and Cash Flow in FY 2023 WESTFORD, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) reported its financial results for the fourth quarter and fiscal year ended December 30, 2023. Fourth Quarter Financial Highlights   Revenue increased 3% to $239 million   Operating cash flow increased 68% to $59 million Free cash flow increased 114% to $49 million Net income increased 5% to $27 million GAAP EPS increased 4% to $2.33 Adjusted EPS increased 3% to $2.41 Adjusted EBITDA decreased 2% to $48 million and represented 20.3% of revenue Bookings increased 1% to $218 million Fiscal Year Financial Highlights   Revenue increased 6% to a record $958 million   Operating cash flow increased 61% to a record $166 million Free cash flow increased 80% to $134 million Net income decreased 4% to $116 million GAAP EPS...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.